The Korea National Institute of Health, under the Korea Disease Control and Prevention Agency, announced on the 17th that it ...
A groundbreaking study reveals that cancer patients who received a COVID-19 mRNA vaccine within 100 days of starting ...
LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Growth Forecast: What To Expect By 2025? In recent years, the ...
Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy ...
Moderna faces significant uncertainty ahead of Q3 earnings, with heavy reliance on COVID vaccine revenues and limited ...
StockStory.org on MSN
2 Mid-Cap Stocks to Consider Right Now and 1 That Underwhelm
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large ...
The move came after the FDA approved updated shots only for people aged 65 and over and those at risk of severe disease. The ...
More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV ...
Opinion
Jacksonville Journal-Courier on MSNCommentary: Musings by Ed Anderson — Risk emerges when political views collide with science
An example of this conflict occurred in the 1920s when Trofim Lysenko, a Soviet biologist, rejected natural selection in ...
Kernal has been awarded up to $48M funding to accelerate the development of KR-402, a next-generation in vivo CAR T-cell ...
AZoLifeSciences on MSN
Advances in Gene Silencing and Editing for Rare Disorders
Significant advancements in gene silencing and gene editing offer new hope for treating rare disorders. Techniques like RNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results